Effects on Smooth Muscle Preparations of Unidentified Vasoactive Peptides from Intestine and Lung

No abstract is available for this paper.

• Publication year

  1970

• Venue

  Nature

• Publication date

  1970-03-21

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/2251144A0PMID 4392130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE

  1997cited by this paper
• THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD

  1997cited by this paper
• The technique of superfusion

  1997cited by this paper
• Potent Peripheral and Splanchnic Vasodilator Peptide from Normal Gut

  1970cited by this paper
• Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs

  1969cited by this paper
• A peptide fraction from lung tissue with prolonged peripheral vasodilator activity.

  1969cited by this paper
• Long Acting Vasodilator Peptide from Lung Tissue

  1969cited by this paper
• Prostaglandins released by the Spleen

  1968cited by this paper
• An analysis of the responses of the isolated portal vein of the rabbit to electrical stimulation and to drugs.

  1967cited by this paper
• The detection and estimation of bradykinin in the circulating blood.

  1967cited by this paper
• A SENSITIVE METHOD FOR THE ASSAY OF ANGIOTENSIN.

  1964cited by this paper
• Human urinary kinin excretion.

  1959cited by this paper
• The pharmacology of vascular smooth muscle.

  1955cited by this paper
• The nature of hepatic and splenic sympathin.

  1950cited by this paper
• The pharmacological estimation of adenosine and histamine in blood

  1935cited by this paper

• Detecting age-related changes in faecal vasoactive intestinal polypeptide using a 3D-printed electrochemical immunosensor

  2025cites this paper
• Myopia Pathogenesis and Vasoactive Intestinal Peptide: Molecular Mechanisms, Experimental Models, and Clinical Implications.

  2025cites this paper
• Pharmacology of Gut Hormone Mimetics for Obesity and Diabetes

  2021cites this paper
• Three-dimensional analysis of neural connectivity with cells in rat ileal mucosa by serial block-face scanning electron microscopy

  2020cites this paper
• The anorexigenic effect of vasoactive intestinal polypeptide in Japanese quail is associated with molecular changes in the arcuate and dorsomedial hypothalamic nuclei.

  2020cites this paper
• Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery.

  2015cites this paper
• Vasoactive intestinal peptide receptor-based imaging and treatment of tumors (Review).

  2014influential citation
• Development of Latent Cytokine Fusion Proteins

  2013cites this paper
• Biological effects of vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor 1 (VPAC1) and VPAC2 on chemotaxis and its regulation of the tumor suppressor Ikaros in leukemic T cells

  2012cites this paper
• Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.

  2011cites this paper
• Small but powerful: short peptide hormones and their role in autoimmune inflammation.

  2009cites this paper
• VPAC and PAC receptors: From ligands to function.

  2009cites this paper
• VIP: Molecular biology and neurobiological function

  2007cites this paper
• Expression and fine mapping of murine vasoactive intestinal peptide receptor 1

  2007cites this paper
• PROMOTES CYCLIC ADENOSINE 3',5'-MONO- PHOSPHATE ACCUMULATION IN GUINEA-PIG TRACHEA

  2006cites this paper
• The expression of heat shock protein 70, heat shock protein 90 and heat shock factor 1 within the bovine midcycle corpus luteum after stimulation with temperature in vitro and PGF2alpha in vitro and in vivo

  2006cites this paper
• The Neuropeptide VIP and the IL-6 Family of Cytokines in Bone - Effects on Bone Resorption, Cytokine Expression and Receptor Signalling in Osteoblasts and Bone Marrow Stromal Cells

  2005cites this paper
• Occurrence and distribution of GRP-immunoreactive nerve fibres in the respiratory tract

  2004cites this paper
• The Significance of Vasoactive Intestinal Peptide in Immunomodulation

  2004cites this paper
• Therapeutic approaches of vasoactive intestinal peptide as an immunomodulatory cytokine

  2004cites this paper
• Studies of the guinea-pig epididymis

  2004cites this paper
• Origin and distribution of VIP (Vasoactive Intestinal Polypeptide)-nerves in the genito-urinary tract

  2004cites this paper
• The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide?

  2004cites this paper
• Ileal VIP submucous neurons: confocal study of the area enlargement induced by myenteric denervation in weanling rats.

  2004cites this paper
• Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cats, and human subjects

  2004cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2003cites this paper
• Age-dependent levels of plasma neuropeptides in normal children.

  2002cites this paper
• The differential effect of VIP and PACAP on guinea pig gallbladder in vitro

  2000cites this paper
• The Viktor Mutt Memorial Lecture Protection by VIP and Related Peptides Against Cell Death and Tissue Injury

  2000cites this paper
• The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy.

  1999cites this paper
• Non-adrenergic non-cholinergic relaxation of the rat stomach.

  1998cites this paper
• The history of neuropeptides III.

  1996cites this paper
• The history of neuropeptides II.

  1996cites this paper
• Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins.

  1995cites this paper
• Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic beta cells. Evidence for improved glucose tolerance and enhanced insulin secretion by VIP and PHM-27 in vivo.

  1994cites this paper
• Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family.

  1993cites this paper
• Neuronal control of airways smooth muscle.

  1993cites this paper
• Frequency dependence of vasoactive intestinal polypeptide release and vagally induced tachycardia in the canine heart.

  1993cites this paper
• Water and ion shifts in mouse intestinal cells following VIP stimulation.

  1993cites this paper
• Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.

  1992cites this paper
• Effects of vasoactive intestinal peptide (VIP) on contractile responses of smooth muscle in rat stomach

  1991cites this paper
• Vasoactive Intestinal Polypeptide (VIP) in Asthma a

  1991cites this paper
• Vasoactive intestinal polypeptide (VIP) in asthma.

  1991cites this paper
• Assays for Vasoactive Intestinal Peptide Receptor

  1991cites this paper
• Structural determination of the vasoactive intestinal peptide by two‐dimensional 1H‐nmr spectroscopy

  1991cites this paper
• Parasympathetic innervation of cutaneous blood vessels examined by retrograde tracing in the rat lower lip.

  1991cites this paper
• The complete structure of the rat VIP gene.

  1990cites this paper
• [Experimental studies on VIP containing nerve in canine bladder neck].

  1990cites this paper
• Vasoactive peptides and their receptors.

  1990cites this paper
• A glucagon-secretin-like peptide stimulates the intrinsic nervous plexus of guinea pig gallbladder

  1990cites this paper
• Vasoactive intestinal peptide

  1989cites this paper
• Vasoactive intestinal peptide (VIP), a putative neurotransmitter of nonadrenergic, noncholinergic (NANC) inhibitory innervation and its relevance to therapy.

  1989cites this paper
• Immuno-affinity purification of specific antibodies against vasoactive intestinal polypeptide (VIP) on VIP (1-10)-linked polydimethylacrylamide resin.

  1989cites this paper
• 7 Vasoactive intestinal peptide

  1989cites this paper
• Pharmacology of biliary tract

  1989cites this paper
• Modulation of cholinergic neurotransmission by vasoactive intestinal peptide in ferret trachea.

  1988cites this paper
• Anatomical Distribution of Vasoactive Intestinal Peptide Binding Sites in Peripheral Tissues Investigated by in Vitro Autoradiography a

  1988cites this paper
• Vasoactive Intestinal Peptide in the Lung

  1988cites this paper
• Somatostatin and methionine-enkephalin inhibit cholera toxin-induced jejunal net fluid secretion and release of vasoactive intestinal polypeptide in the cat in vivo.

  1988cites this paper
• Similarities between the relaxations induced by vasoactive intestinal peptide and by stimulation of the non-adrenergic non-cholinergic neurons in the rat stomach

  1988cites this paper
• Release of vasoactive intestinal polypeptide anally of a local distension of the feline small intestine.

  1987cites this paper
• Innervation of airway smooth muscle. Efferent mechanisms.

  1987cites this paper
• Distribution of nerves containing vasoactive intestinal polypeptide-like immunoreactivity in rats with congenital aganglionosis of the colon.

  1987cites this paper
• Cyclic fluctuations of vasoactive intestinal polypeptide measured radioimmunologically in various regions of the human fallopian tube.

  1987cites this paper
• Electrophysiology and morphology of vasoactive‐intestinal‐peptide‐immunoreactive neurones of the guinea‐pig ileum.

  1986cites this paper
• cAMP immunocytochemistry provides evidence for functional VIP receptors in trachea.

  1986cites this paper
• Study on the possible neurotransmitter of the non-adrenergic non-cholinergic innervation of the rat gastric fundus.

  1986cites this paper
• Thyroid hormone modulation of VIP’s induced salivary secretion in the submaxillary glands of rats

  1986cites this paper
• Effects of avian pancreatic peptide on smooth muscle relaxations by vasoactive intestinal peptide and inhibitory nerve stimulation.

  1986cites this paper
• Vasoactive intestinal peptide stimulates cyclic AMP metabolism in choroid plexus epithelial cells.

  1986cites this paper
• Mechanisms of Transmitter Action in the Vertebrate Central Nervous System

  1986cites this paper
• Neurotransmitters in the intestine of the Atlantic cod, Gadus morhua.

  1985cites this paper
• Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.

  1985cites this paper
• Mechanisms of vasodilation induced by vasoactive intestinal polypeptide in rabbit mesenteric artery.

  1985cites this paper
• Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat.

  1985cites this paper
• [Vasoactive intestinal peptide: a ubiquitous neuropeptide. Implications in digestive physiopathology].

  1985cites this paper
• Effect of vasoactive intestinal peptide on isolated perfused rat kidney.

  1985cites this paper
• Gallbladder Motility and Its Regulation

  1984cites this paper
• Detection of mRNAs containing regulatory peptide coding sequences using synthetic oligodeoxynucleotides

  1984cites this paper
• The effect of VIP on guinea pig taenia coli requires the whole sequence.

  1984cites this paper
• Mechanisms of Gastrointestinal Motility and Secretion

  1984cites this paper
• Evidence for vasoactive intestinal polypeptide as a neurotransmitter in smooth muscle of the urogenital tract.

  1984cites this paper
• Vasoactive intestinal polypeptide influence on lower urinary tract smooth muscle from human and pig.

  1984cites this paper
• Distribution of peptide histidine isoleucine in the mammalian respiratory tract and some aspects of its pharmacology.

  1984cites this paper
• Effect of vasoactive intestinal peptide on vagally mediated tracheal pouch relaxation.

  1984cites this paper
• The effects of vasoactive intestinal polypeptide on the motility of human and guinea pig gallbladder.

  1984cites this paper
• In vivo bronchodilator activity of vasoactive intestinal peptide in the cat.

  1983cites this paper
• Light and electron microscopic immunocytochemical localization of vasoactive intestinal polypeptide VIP-like activity in the rat small intestine.

  1983cites this paper
• Gall-bladder water and electrolyte transport and its regulation.

  1983cites this paper
• Enzymatic disaggregation of the infected rat cornea.

  1983cites this paper
• Regional vascular influences of vasoactive intestinal polypeptide.

  1983cites this paper
• The effects of vasoactive intestinal polypeptide on the electrical activity of guinea-pig intestinal smooth muscle.

  1983cites this paper
• Studies of the guinea pig epididymis

  1983cites this paper
• DISTRIBUTION OF PEPTIDE-CONTAINING ENDOCRINE CELLS AND NEURONS IN THE GASTROINTESTINAL TRACT OF THE DOG: IMMUNOHISTOCHEMICAL STUDIES USING ANTISERA TO SOMATOSTATIN, SUBSTANCE P, VASOACTIVE INTESTINAL POLYPEPTIDE, MET-ENKEPHALIN, AND NEUROTENSIN

  1983cites this paper
• Vasoactive intestinal polypeptide as a neurotransmitter in the female genital tract.

  1983cites this paper
• Monoclonal Antibodies Against Vasoactive Intestinal Polypeptide: Studies of Structure and Related Antigens

  1983cites this paper
• Effects of desensitization to adenosine 5‘‐triphosphate and vasoactive intestinal polypeptide on non‐adrenergic inhibitory responses of longitudinal and circular muscles in the rat ileum

  1983cites this paper
• Vasoactive intestinal peptide-like immunoreactivity in nerves associated with the cardiovascular system of guinea-pigs.

  1983cites this paper
• The quest for the inhibitory neurotransmitter in bovine tracheal smooth muscle.

  1983cites this paper
• Vasoactive intestinal peptide and cholinergic neurotransmission in the ciliary muscle.

  1983cites this paper